AIBullishBlockonomi · Apr 177/10
🧠
OpenAI Unveils GPT-Rosalind: New AI Model Targeting Pharmaceutical Research Acceleration
OpenAI has launched GPT-Rosalind, an AI model designed to accelerate pharmaceutical drug discovery, partnering with major life sciences companies including Amgen, Moderna, and Thermo Fisher. The model represents a significant application of advanced AI technology beyond traditional software domains, with potential to compress drug development timelines and reduce research costs.
🏢 OpenAI